Inventor
FAYADAT-DILMAN LAURENCE
US16 patents
⚠️ This page may combine multiple inventors who share the name “FAYADAT-DILMAN LAURENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
11 patentsUS10188730B2Jan 29, 2019
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME42 citations97
US10766957B2Sep 8, 2020
Anti-TIGIT antibodies
MERCK SHARP & DOHME7 citations82
US10618958B2Apr 14, 2020
Anti-TIGIT antibodies
MERCK SHARP & DOHME10 citations81
US11278620B2Mar 22, 2022
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME3 citations72
US10898571B2Jan 26, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME2 citations72
US11072658B2Jul 27, 2021
Anti-PD-1/LAG3 bispecific antibodies
MERCK SHARP & DOHME5 citations66
US10556957B2Feb 11, 2020
Anti-CD27 antibodies
MERCK SHARP & DOHME4 citations66
US11207406B2Dec 28, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME0 citations62
US11045547B2Jun 29, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME0 citations62
US12441792B2Oct 14, 2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
MERCK SHARP & DOHME0 citations59
US11111297B2Sep 7, 2021
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
MERCK SHARP & DOHME0 citations59
MERCK SHARP & DOHME LLC
5 patentsUS12102681B2Oct 1, 2024
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME LLC0 citations62
US11958902B2Apr 16, 2024
Anti-TIGIT antibodies
MERCK SHARP & DOHME LLC0 citations60
US12435133B2Oct 7, 2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
MERCK SHARP & DOHME LLC0 citations59
US12102680B2Oct 1, 2024
Anti-TIGIT antibodies
MERCK SHARP & DOHME LLC1 citations59
US12122834B2Oct 22, 2024
Anti-PD-1 antibodies
MERCK SHARP & DOHME LLC0 citations47